Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Immunization, Passive × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Pancreatic Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, AIDS-Related 1 Leukemia, Prolymphocytic 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 345 Cytarabine 282 fludarabine phosphate 202 Methotrexate 186 Filgrastim 159 Busulfan 147 Etoposide 135 Peripheral Blood Stem Cell Transplantation 134 fludarabine 127 Rituximab 119 Radiotherapy 111 Vincristine 102 Cyclosporine 97 Daunorubicin 96 Antilymphocyte Serum 94 Dexamethasone 91 Tacrolimus 85 Mycophenolic Acid 85 Whole-Body Irradiation 80 Melphalan 79 Imatinib Mesylate 69 Idarubicin 67 Granulocyte Colony-Stimulating Factor 66 Mercaptopurine 65 Azacitidine 65 Methylprednisolone 59 Doxorubicin 58 Prednisone 57 sargramostim 53 Mitoxantrone 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00515892 2007-08-14

NHL

Cambridge Antibody Technology

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡